Synapse Open Synapse
Biology

CCR8-depleting antibodies restore response to radiotherapy plus anti-PD1 therapy in head and neck cancer by targeting intratumoral CCR8+ regulatory T cells

Nature Biological Sciences · · 1 min read

Previous evidence has implicated regulatory T cells (Tregs) in treatment resistance in head and neck cancer.

Latest from Nature Biological Sciences